Blau Farmacêutica Company Description

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others.

The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics.

It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets.

In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs.

It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions.

The company was incorporated in 1987 and is headquartered in Cotia, Brazil.

Blau Farmacêutica S.A.

Country	Brazil
Founded	1987
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,900
CEO	Marcelo Hahn

Contact Details

Address: Rodovia Raposo Tavares, Cotia, 06705-030 Brazil
Phone	55 11 4615 9400
Website	blau.com

Stock Details

Ticker Symbol	BLAU3
Exchange	Brazil Stock Exchange
Fiscal Year	January - December
Reporting Currency	BRL
ISIN Number	BRBLAUACNOR8
SIC Code	2836

Key Executives

Name	Position
Marcelo Rodolfo Hahn	Founder, Controller, Chief Executive Officer and Deputy Chairman
Douglas Leandro Rodrigues	Chief Financial Officer and Investor Relations Officer
Roberto Carlos de Campos Morais	Chief Operating Officer and Director
Roberto Altieri	Legal and Compliance Officer